A 24-week study to assess blood pressure independent effects of valsartan treatment, benazepril treatment and combination of both valsartan and benazepril treatment on urinary albumin excretion rate with type II diabetes mellitus and microalbuminuria

Trial Profile

A 24-week study to assess blood pressure independent effects of valsartan treatment, benazepril treatment and combination of both valsartan and benazepril treatment on urinary albumin excretion rate with type II diabetes mellitus and microalbuminuria

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 16 Dec 2008

At a glance

  • Drugs Benazepril; Valsartan
  • Indications Hypertension; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 16 Dec 2008 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top